Abstract
To examine the proper margin for breast conservative surgery in Chinese women population. 40 breast cancer specimens were collected and each sample was dissected into several groups: primary tumor group, 1 cm paracarcinoma, 2 cm paracarcinoma, 3 cm paracarcinoma and excessive 3 cm paracarcinoma groups. The immunohistochemistry staining was performed to measure the expression levels of proliferating cell nuclear antigen (PCNA), c-erbB-2, p53, estrogen receptor (ER) and progesterone receptor (PR). The gene expressions of PCNA, c-erbB-2, and p53 gradually decreased with the increased distance from primary tumor (P < 0.05). The 1 and 2 cm paracarcinoma group (no differences between the two, P > 0.05) showed higher risk factors (c-erbB-2, p53) than the 3 cm and excessive 3 cm paracarcinoma groups (P < 0.05). The expression of PCNA, ER, and PR showed no correlation with cancer progression (P > 0.05). Beyond the paracarcinoma 2 cm distance, the tissues showed significant decreases in tumor gene expression, which could represent the appropriate region for breast conservative surgery.
Similar content being viewed by others
References
Kato T, Kameoka S, Kimura T, Nishikawa T, Kobayashi M (2002) C-erbB-2 and PCNA as prognostic indicators of long-term survival in breast cancer. Anticancer Res 22:1097–1103
Khoury MP, Bourdon JC (2011) p53 Isoforms: an intracellular microprocessor? Genes Cancer 2:453–465. doi:10.1177/1947601911408893
Kumar S, Walia V, Ray M, Elble RC (2007) p53 in breast cancer: mutation and countermeasures. Front Biosci 12:4168–4178
Law TT, Kwong A (2009) Surgical margins in breast conservation therapy: how much should we excise? Southern Med J 102:1234–1237. doi:10.1097/SMJ.0b013e3181bfd420
Lopez-Guerrero JA, Navarro S, Noguera R, Almenar S, Pellin A, Vazquez C, Llombart-Bosch A (2003) Histological tumor grade correlates with HER2/c-erB-2 status in invasive breast cancer: a comparative analysis between immunohistochemical (CB11 clone and Herceptest), FISH and differential PCR procedures. Arkh Patol 65:50–55
Luini A, Rososchansky J, Gatti G et al (2009) The surgical margin status after breast-conserving surgery: discussion of an open issue. Breast Cancer Res Treat 113:397–402. doi:10.1007/s10549-008-9929-0
Malkas LH, Herbert BS, Abdel-Aziz W et al (2006) A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker. Proc Natl Acad Sci USA 103:19472–19477. doi:10.1073/pnas.0604614103
McCann A, Johnston PA, Dervan PA, Gullick WJ, Carney DN (1989) c-erB-2 oncoprotein expression in malignant and nonmalignant breast tissue. Ir J Med Sci 158:137–140
Morrow M (2009) Breast conservation and negative margins: how much is enough? Breast 18(Suppl 3):S84–S86. doi:10.1016/S0960-9776(09)70279-6
Munhoz AM, Montag E, Arruda E et al (2009) Immediate reconstruction following breast-conserving surgery: management of the positive surgical margins and influence on secondary reconstruction. Breast 18:47–54. doi:10.1016/j.breast.2008.10.005
Royds JA, Iacopetta B (2006) p53 and disease: when the guardian angel fails. Cell Death Differ 13:1017–1026. doi:10.1038/sj.cdd.4401913
Yamashiro N, Tozaki M, Ogawa T et al (2009) Preoperative MRI marking technique for the planning of breast-conserving surgery. Breast Cancer 16:223–228. doi:10.1007/s12282-008-0088-2
Zavagno G, Goldin E, Mencarelli R et al (2008) Role of resection margins in patients treated with breast conservation surgery. Cancer 112:1923–1931. doi:10.1002/cncr.23383
Acknowledgments
The work was supported by Shanxi Science and Technology Research and Development grant 2003K10-G36.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jia, Z., Zhao, W., Fan, L. et al. The expression of PCNA, c-erbB-2, p53, ER and PR as well as atypical hyperplasia in tissues nearby the breast cancer. J Mol Hist 43, 115–120 (2012). https://doi.org/10.1007/s10735-011-9371-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-011-9371-1